The Claim
The omega-6/omega-3 oxylipin ratio in plasma is associated with an adverse cardiometabolic profile in middle-aged adults, characterized by higher insulin resistance, dyslipidemia, and elevated liver enzymes, independent of traditional risk factors.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In middle-aged adults, a higher ratio of omega-6 to omega-3 oxylipins in the blood is linked to worse metabolic health, including increased insulin resistance, abnormal blood fats, and higher liver enzyme levels, even when accounting for standard risk factors like obesity and smoking.
See the scientific wording
The omega-6/omega-3 oxylipin ratio in plasma reflects an adverse cardiometabolic profile in middle-aged adults, including higher insulin resistance, dyslipidemia, and liver enzyme elevation, independent of traditional risk factors.
When there is too much omega-6 fat compared to omega-3 fat in the blood, the body produces more inflammatory signaling molecules from omega-6 fats and fewer anti-inflammatory ones from omega-3 fats. These inflammatory molecules block insulin's ability to help cells take up sugar, raise blood sugar levels, and cause fat buildup and damage in the liver, which releases stress enzymes into the blood.
What the research says
1 studyThis study found that when middle-aged adults have more omega-6 fats than omega-3 fats in their blood, they tend to have worse blood sugar control, higher bad cholesterol, and signs of liver stress — even when accounting for weight and diet. So yes, the balance of these fats is a good sign of metabolic health.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.